Histologic Grading of Noninvasive Papillary Urothelial Neoplasms

European Urology

Volumn 51, Issue 4, 2007, Pages 889-898

  MacLennan, Gregory T ^a   Kirkali, Ziya ^b   Cheng, Liang ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Grading; Neoplasia; Papillary urothelial neoplasm of low malignant potential (PUNLMP); Transitional cell carcinoma; Urinary bladder; WHO ISUP classification

Indexed keywords

ANTIINFECTIVE AGENT; BCG VACCINE; MOLECULAR MARKER;

BLADDER TUMOR; CANCER GRADING; CANCER PATIENT; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; GENE EXPRESSION; GENOME; HUMAN; MEDLINE; MORPHOLOGY; NOMENCLATURE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; REPRODUCIBILITY; REVIEW; SCIENTIFIC LITERATURE; URINE CYTOLOGY; UROGENITAL TRACT TUMOR; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION;

CARCINOMA, TRANSITIONAL CELL; HUMANS; URINARY BLADDER NEOPLASMS; WORLD HEALTH ORGANIZATION;

EID: 33847095882     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.10.037     Document Type: Review

References (38)

1. Droller M.J. Bladder cancer: state-of-the-art care. CA Cancer J Clin 48 (1998) 269-284
2. Mostofi F.K., Sobin L.H., and Torloni H. Histological typing of urinary bladder tumours (1973), World Health Organization, Geneva, Switzerland
3. Cheng L., Darson M., Cheville J.C., et al. Urothelial papilloma of the bladder: clinical and biologic implications. Cancer 86 (1999) 2098-2101
4. Bostwick D.G., and Mikuz G. Urothelial papillary (exophytic) neoplasms. Virchows Arch 441 (2002) 109-116
5. Jones T.D., and Cheng L. Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts. J Urol 175 (2006) 1995-2003
6. Lopez-Beltran A., and Montironi R. Non-invasive urothelial neoplasms: according to the most recent WHO classification. Eur Urol 46 (2004) 170-176
7. Eble J.N., Sauter G., Epstein J.I., Sesterhenn I.A.E., and World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs (2004), IARC Press, Lyon, France p. 89-158
8. Epstein J.I., Amin M.B., Reuter V.R., and Mostofi F.K. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22 (1998) 1435-1448
9. Cheng L., Neumann R.M., and Bostwick D.G. Papillary urothelial neoplasms of low malignant potential: clinical and biological implications. Cancer 86 (1999) 2102-2108
10. Holmang S., Andius P., Hedelin H., Wester K., Busch C., and Johansson S.L. Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J Urol 165 (2001) 1124-1130
11. Pich A., Chiusa L., Formiconi A., et al. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder. Cancer 95 (2002) 784-790
12. Samaratunga H., Makarov D.V., and Epstein J.I. Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. Urology 60 (2002) 315-319
13. Fujii Y., Kawakami S., Koga F., Nemoto T., and Kihara K. Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential. BJU Int 92 (2003) 559-562
14. Holmang S., Hedelin H., Anderstrom C., Holmberg E., Busch C., and Johansson S.L. Recurrence and progression in low grade papillary urothelial tumors. J Urol 162 (1999) 702-707
15. Oosterhuis J.W., Schapers R.F., Janssen-Heijnen M.L., Pauwels R.P., Newling D.W., and ten Kate F. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems. J Clin Pathol 55 (2002) 900-905
16. Cheng L., Neumann R.M., Nehra A., Spotts B.E., Weaver A.L., and Bostwick D.G. Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer 88 (2000) 1663-1670
17. Cheng L., MacLennan G.T., Zhang S., Wang M., Pan C.X., and Koch M.O. Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder. Cancer 101 (2004) 183-188
18. van Rhijn B.W., Montironi R., Zwarthoff E.C., Jobsis A.C., and van der Kwast T.H. Frequent FGFR3 mutations in urothelial papilloma. J Pathol 198 (2002) 245-251
19. Pich A., Chiusa L., Formiconi A., Galliano D., Bortolin P., and Navone R. Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder. Am J Surg Pathol 25 (2001) 1528-1533
20. Coblentz T.R., Mills S.E., and Theodorescu D. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma. Cancer 91 (2001) 1284-1290
21. Mikuz G. The reliability and reproducibility of the different classifications of bladder cancer. In: Haupmann S., Dietel M., and Sorbrinho-Simoes M. (Eds). Surgical pathology update 2001 (2001), ABW-Wissenschaftsverlag, Berlin 114-115
22. Yorukoglu K., Tuna B., Dikicioglu E., et al. Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder. Virchows Arch 443 (2003) 734-740
23. Murphy W.M., Takezawa K., and Maruniak N.A. Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms: practical choices for patient care. J Urol 168 (2002) 968-972
24. Whisnant R.E., Bastacky S.I., and Ohori N.P. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification. Diagn Cytopathol 28 (2003) 186-190
25. Bircan S., Candir O., and Serel T.A. Comparison of WHO 1973, WHO/ISUP 1998, WHO 1999 grade and combined scoring systems in evaluation of bladder carcinoma. Urol Int 73 (2004) 201-208
26. Yin H., and Leong A.S. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up. Am J Clin Pathol 121 (2004) 679-687
27. Curry J.L., and Wojcik E.M. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results. Cancer 96 (2002) 140-145
28. Cheng L., Neumann R.M., Weaver A.L., et al. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. Am J Clin Pathol 113 (2000) 275-279
29. Cheng L., and Bostwick D.G. World Health Organization and International Society of Urological Pathology classification and two-number grading system of bladder tumors: reply. Cancer 88 (2000) 1513-1516
30. Cheng L., Neumann R.M., Weaver A.L., Spotts B.E., and Bostwick D.G. Predicting cancer progression in patients with stage T1 bladder carcinoma. J Clin Oncol 17 (1999) 3182-3187
31. Cheng L., Neumann R.M., Scherer B.G., et al. Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma: a critical evaluation of the depth of muscle invasion. Cancer 85 (1999) 2638-2647
32. Cheng L., Weaver A.L., Leibovich B.C., et al. Predicting the survival of bladder carcinoma patients treated with radical cystectomy. Cancer 88 (2000) 2326-2332
33. Cheng L., Cheville J.C., Leibovich B.C., et al. Survival of patients with carcinoma in situ of the urinary bladder. Cancer 85 (1999) 2469-2474
34. Cheng L., Cheville J.C., Neumann R.M., and Bostwick D.G. Natural history of urothelial dysplasia of the bladder. Am J Surg Pathol 23 (1999) 443-447
35. Cheng L., Cheville J.C., Neumann R.M., and Bostwick D.G. Flat intraepithelial lesions of the urinary bladder. Cancer 88 (2000) 625-631
36. Cheng L., Weaver A.L., and Bostwick D.G. Predicting extravesical extension of bladder carcinoma: a novel method based on micrometer measurement of the depth of invasion in transurethral resection specimens. Urology 55 (2000) 668-672
37. Cheng L., Weaver A.L., Neumann R.M., Scherer B.G., and Bostwick D.G. Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer. A new proposal. Cancer 86 (1999) 1035-1043
38. Montironi R., Scarpelli M., De Nictolis M., Mariuzzi G., Ansuini G., and Pisani E. Comparison of computerized analysis of nuclear DNA changes in uterine cervix dysplasia and in urothelial non-invasive papillary carcinoma. Pathol Res Pract 183 (1988) 489-496